By Connor Hart
Codexis has named Georgia Erbez as its chief financial officer, succeeding Sri Ryali.
Erbez most recently served as chief operating officer at Walking Fish Therapeutics, a private B-cell therapy company. Prior, she has held executive roles at companies including Harpoon Therapeutics, Zosano Pharma and Revolution Medicines, the enzyme-engineering company said Wednesday.
Codexis also named Alison Moore to the newly-created role of chief technology officer, and named John Schiffhauer as senior vice president of intellectual property.
Also on Wednesday, the company announced an increase in its cash reserves through capital raises totaling $31 million.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
October 02, 2024 16:24 ET (20:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。